Vanguard Group’s Gain Therapeutics GANX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $962K | Buy |
534,352
+279,362
| +110% | +$503K | ﹤0.01% | 3753 |
|
|
2025
Q1 | $487K | Buy |
254,990
+77,915
| +44% | +$149K | ﹤0.01% | 3891 |
|
|
2024
Q4 | $382K | Buy |
177,075
+31,858
| +22% | +$68.8K | ﹤0.01% | 3998 |
|
|
2024
Q3 | $258K | Hold |
145,217
| – | – | ﹤0.01% | 4095 |
|
|
2024
Q2 | $186K | Buy |
145,217
+25,853
| +22% | +$33.1K | ﹤0.01% | 4176 |
|
|
2024
Q1 | $450K | Buy |
119,364
+30,979
| +35% | +$117K | ﹤0.01% | 4043 |
|
|
2023
Q4 | $289K | Buy |
88,385
+18,105
| +26% | +$59.1K | ﹤0.01% | 4164 |
|
|
2023
Q3 | $231K | Buy |
70,280
+6,162
| +10% | +$20.2K | ﹤0.01% | 4228 |
|
|
2023
Q2 | $287K | Buy |
64,118
+11,513
| +22% | +$51.6K | ﹤0.01% | 4246 |
|
|
2023
Q1 | $254K | Buy |
+52,605
| New | +$254K | ﹤0.01% | 4282 |
|